Hero image

About our company

We invent for a more hopeful future.

We aspire to be the premier research-intensive biopharmaceutical company in the world

For more than 125 years, Merck (known as MSD outside of the U.S. and Canada) has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives.

We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships.

Today, we continue to be at the forefront of research to prevent and treat diseases that threaten people and animals – including cancer, infectious diseases, such as HIV and Ebola, and emerging animal diseases.

women harvesting tea leaves with basket
Responsibility

The heart of our mission

We believe corporate responsibility is about our health, social, environmental and economic impact on people and communities around the world.

Merck leadership on stage
Leadership

The team that guides our work

Our leaders focus on our mission to save and improve lives around the world. This is the foundation of everything we do.

Our company by the numbers

71K

employees

Our culture
$9.9B

research and development investment in 2019

Our research
$2.8B

total philanthropy in 2018

Our giving
group of scientists working together in lab
Culture & values

Our values are driven by a desire to improve life

We’ve built a culture that embraces scientific excellence, operates with the highest standards of integrity, expands access to our products and employs a diverse workforce that values collaboration.

Black and white photo of George W. Merck
History

Our past and our future

For more than 125 years, we’ve focused on not just the next quarter, but the next quarter century.

Get to know us through our stories

Learn about the heartbeat of our company.

View our stories

Businesses have a role to play in building vaccine trust. Here’s why

Employers are trusted messengers of credible information on vaccines

Read more

Next: Businesses have a role to play in building vaccine trust. Here’s why

Our third-quarter 2020 financial results

Merck announced third-quarter worldwide sales of $12.6 billion – an increase of 1% compared with the third quarter of 2019. Excluding the impact from foreign exchange, sales grew 2%. The company anticipates full-year 2020 revenue range to be between $47.6 billion and $48.6 billion, including a negative impact from foreign exchange of approximately 1.5%. Take […]

Read more

Next: Our third-quarter 2020 financial results

When breast cancer hits home

A perspective on courage and perseverance

Read more

Next: When breast cancer hits home

Merck named to Forbes Just 100 list for “doing right by America”

Forbes and JUST Capital also awarded Merck the highest ranking in Pharmaceuticals & Biotech, including the top spot among the industry for “Customers”

Read more

Next: Merck named to Forbes Just 100 list for “doing right by America”

Merck publishes 2019/2020 corporate responsibility report

Letter from our chairman and CEO, Ken Frazier

Read Ken's letter

Next: Merck publishes 2019/2020 corporate responsibility report

Previous
Next

Our areas of focus

We focus on scientific innovation to deliver medicines and vaccines that may help millions of people around the world.

Oncology

Our mission is to deliver innovations that extend and improve the lives of people with cancer.

Learn about oncology

Vaccines

Vaccines are one of the greatest public health success stories – and we’ve been discovering, developing and delivering vaccines to help prevent disease for over 100 years.

Learn about vaccines

Infectious diseases

We play an important role in discovering and developing innovative medicines and vaccines to treat and prevent infectious diseases, including HIV and Ebola.

Learn about infectious diseases

COVID-19

As a company dedicated to saving and improving lives, we have a special responsibility to help in the fight against COVID-19. We’ve been fully committed to developing an effective response to the COVID-19 pandemic since it was first recognized.

Learn more about our response to COVID-19

Cardio-metabolic disorders

We are determined to find solutions for the most serious chronic health challenges, such as cardiovascular disease and diabetes.

Learn about cardio-metabolic disorders

Discovery & development

We are pushing the boundaries in research where we can make the greatest difference, now and in the future.

Learn about our work

Dog owner holding out a ball for an attentive Labrador

Merck Animal Health

Merck Animal Health is a research-driven company that develops, manufactures and markets a broad range of veterinary medicines and services.

We offer one of the industry’s most innovative portfolios, spanning products for the prevention, treatment and control of disease in all major farm and companion animal species.

Business partnerships and public policies keep our patients in focus

Column one image

Business development & licensing

We work with partners, from early-stage science to clinical-stage programs, to deliver new therapies to patients.

Column one image

Policies & positions

We support public policies that advance the interests of patients, improve public health and promote access to medicines and innovation.